Výsledky vyhľadávania - "Harrison SA"

Safety and Efficacy of FGF21 Analogues in Nonalcoholic Steatohepatitis: A Meta-Analysis of Randomized Clinical Trials.

Autori: Sobral, Milene Vitória Sampaio Faria, Hilária Saugo Bendaham, Lucas Cael Azevedo Ramos a ďalší

Zdroj: American Journal of Therapeutics; Jul/Aug2025, Vol. 32 Issue 4, pe360-e363, 4p

Letter: Enhancing cirrhosis management-The critical role of social workers in supporting NAFLD surveillance: Authors' reply.

Autori: Tran S Henry L Nguyen MH

Zdroj: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Oct; Vol. 60 (8), pp. 1152-1153. Date of Electronic Publication: 2024 Sep 09.

Spôsob vydávania: Letter

Informácie o časopise: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Výrazy zo slovníka MeSH: Non-alcoholic Fatty Liver Disease*/therapy , Non-alcoholic Fatty Liver Disease*/epidemiology , Liver Cirrhosis*, Humans

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply.

Autori: McPherson S Dyson JK Jopson L a ďalší

Zdroj: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Oct; Vol. 60 (7), pp. 980-981. Date of Electronic Publication: 2024 Aug 30.

Spôsob vydávania: Letter

Informácie o časopise: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: In Process; MEDLINE

Editorial: Decoding the enigma-Navigating complexity in MASLD management. Authors' reply.

Autori: Alkhouri N Bayne AV Chalasani N

Zdroj: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Sep; Vol. 60 (6), pp. 817-818. Date of Electronic Publication: 2024 Jul 22.

Spôsob vydávania: Editorial

Informácie o časopise: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Výrazy zo slovníka MeSH: Non-alcoholic Fatty Liver Disease*/therapy, Humans

Editorial: ARFI-based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity-Authors' reply.

Autori: Dominik N Semmler G Hartl L a ďalší

Zdroj: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jul; Vol. 60 (2), pp. 282-283. Date of Electronic Publication: 2024 May 25.

Spôsob vydávania: Editorial; Comment

Informácie o časopise: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Výrazy zo slovníka MeSH: Obesity, Morbid*, Humans ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/diagnosis

Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals.

Autori: Au, Kahei Zheng, Ming-Hua Lee, Wei-Jei a ďalší

Zdroj: Current Obesity Reports; Dec2024, Vol. 13 Issue 4, p818-830, 13p

Farnesoid X Receptor Agonist in Patients With NAFLD: A Meta-Analysis of Metabolic Benefit and Risk.

Autori: Wang, Yumeng Shou, Xintian Zhang, Ping a ďalší

Zdroj: American Journal of Therapeutics; Jul/Aug2025, Vol. 32 Issue 4, pe364-e368, 5p

Editorial: Crystalising the burden of steatotic liver disease-Authors' reply.

Autori: Schneider CV Schneider KM Loomba R

Zdroj: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 May; Vol. 59 (10), pp. 1294-1295.

Spôsob vydávania: Editorial; Comment

Informácie o časopise: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Výrazy zo slovníka MeSH: Non-alcoholic Fatty Liver Disease*, Humans ; Cost of Illness ; Fatty Liver

Editorial: The evolving paradigms and treatments for primary biliary cholangitis-Authors' reply.

Autori: Mayo MJ Vierling JM Bowlus CL

Zdroj: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jan; Vol. 59 (2), pp. 282.

Spôsob vydávania: Editorial; Comment

Informácie o časopise: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Výrazy zo slovníka MeSH: Liver Cirrhosis, Biliary*/diagnosis , Liver Cirrhosis, Biliary*/drug therapy , Cholangitis*/diagnosis , Cholangitis*/drug therapy , Cholangitis, Sclerosing*, Humans

Comparison of pharmacological therapies in metabolic dysfunction–associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis.

Autori: Souza, Matheus Al-Sharif, Lubna Antunes, Vanio L.J. a ďalší

Zdroj: Hepatology (02709139); 12/1/2025, Vol. 82 Issue 6, p1523-1533, 11p

Call to action—Pediatric MASLD requires immediate attention to curb health crisis.

Autori: Hartmann, Phillipp Mouzaki, Marialena Hassan, Sara a ďalší

Zdroj: Hepatology (02709139); Nov2025, Vol. 82 Issue 5, p1341-1351, 11p

Editorial: Liver hypercortisolism as a potential target for MASH treatment-Authors' reply.

Autori: Kim Y Hwang I Lee SW

Zdroj: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Dec; Vol. 58 (11-12), pp. 1240-1241.

Spôsob vydávania: Editorial; Comment

Informácie o časopise: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Výrazy zo slovníka MeSH: Cushing Syndrome*/drug therapy, Humans ; Liver Cirrhosis ; Abdomen

Authors' reply.

Autori: Tandon, Deepti Singh, Arpita Kerkar, Shilpa a ďalší

Zdroj: Indian Journal of Dermatology, Venereology & Leprology; Jan/Feb2025, Vol. 91 Issue 1, p1-2, 2p

Predmety: GENITALIA infections, SEXUALLY transmitted diseases, MEDICAL research, DRUG resistance in microorganisms, SEXUAL partners, CONDOM use

Resmetirom in the management of metabolic associated steatohepatitis (MASH): a review of efficacy and safety data from clinical trials.

Autori: Ogieuhi, Ikponmwosa Jude Olatunji, Gbolahan Kokori, Emmanuel a ďalší

Zdroj: Egyptian Journal of Internal Medicine; 6/2/2025, Vol. 37 Issue 1, p1-12, 12p

Predmety: HEPATIC fibrosis, THYROID hormone receptors, CLINICAL trials, NON-alcoholic fatty liver disease, MEDICAL sciences

Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study.

Autori: Lee, Jenny Westphal, Max Vali, Yasaman a ďalší

Zdroj: Hepatology (02709139); Jul2023, Vol. 78 Issue 1, p258-271, 14p

Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk.

Autori: Georgakis, Marios K. Malik, Rainer Bounkari, Omar El a ďalší

Zdroj: Genome Medicine; 3/21/2025, Vol. 17 Issue 1, p1-14, 14p

Predmety: DISEASE risk factors, MYOCARDIAL infarction, CORONARY artery disease, MEDICAL sciences, MEDICAL genetics

Unveiling Resmetirom: A systematic review and meta‐analysis on its impact on liver function and safety in non‐alcoholic steatohepatitis treatment.

Autori: Hashim, Hashim Talib Alhatemi, Ahmed Qasim Mohammed Riaz, Sania a ďalší

Zdroj: JGH Open; Oct2024, Vol. 8 Issue 10, p1-8, 8p

Predmety: GLOBAL burden of disease, LIVER histology, RANDOMIZED controlled trials, ALANINE aminotransferase, LIVER diseases

A new investigation of nonalcoholic fatty liver disease: Effects of hypoxia on mitochondrial function and lipid droplet autophagy.

Autori: Tian, Meiyuan Zhang, Yaogang Liu, Zhe a ďalší

Zdroj: PLoS ONE; 9/25/2025, Vol. 20 Issue 9, p1-13, 13p

Predmety: NON-alcoholic fatty liver disease, MITOCHONDRIA, PHENOTYPIC plasticity, INFLUENCE of altitude, LIPOLYSIS, OLEIC acid, HYPOXEMIA

Identifying and Treating Metabolic Dysfunction-Associated Steatotic Liver Disease Among At-Risk Veterans.

Autori: Niezen, Sebastian Morgan, Timothy R. Scott, Dawn a ďalší

Zdroj: American Journal of Gastroenterology (Lippincott Williams & Wilkins); Nov2025, Vol. 120 Issue 11, p2559-2566, 8p

Predmety: FATTY liver, VETERANS' health, METABOLIC disorders, DIAGNOSIS, GLUCAGON-like peptide-1 agonists, DISEASE risk factors, REGULATION of body weight, CIRRHOSIS of the liver

Korporácia: UNITED States. Veterans Health Administration, UNITED States. Dept. of Veterans Affairs

Research trends on the quality of life in patients with metabolic dysfunction-associated fatty liver diseases: a scientific metrology study.

Autori: Huang, Can Chen, Meng Sun, Yanfang a ďalší

Zdroj: Frontiers in Nutrition; 2025, p1-16, 16p